Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) — Form 8-K: Current report
About this filing
Iovance Biotherapeutics, Inc. (IOVA) filed an 8-K on Nov 5, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More IOVA filings
- 4
Filed Nov 10, 2026
- SC 13G
Filed Nov 10, 2026
- 8-K
Filed Nov 5, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.